Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Index

Site index

A consolidated map of IbogaBase desks, reference lanes, claim checks, media shelves, and trackers. Educational only — no dosing or referrals.

Core desks

DeskEvidence by condition DeskSafety DeskClaim checks DeskPolicy DeskCulture DeskTrackers

Reference lanes

CompareIboga vs ibogaine vs noribogaine PlantIboga AlkaloidIbogaine MetaboliteNoribogaine DerivativesAnalogs SafetySafety and QTc EvidenceEvidence by condition Field mapDickinson / bicameral map LawPolicy and law CultureCulture and stewardship MediaPodcasts and media ObservatoryClinic claims and adverse events

Evidence by condition

ConditionOpioid use disorder ConditionAlcohol use disorder ConditionTraumatic brain injury ConditionPTSD and trauma ConditionDepression and mood ConditionParkinson's ConditionWithdrawal ConditionCravings ConditionNeuropathic pain ConditionMultiple sclerosis

Claim checks

VerdictCures addiction VerdictNoribogaine FDA approval VerdictNatural means safe VerdictClinic success rate VerdictBicameral mind theory VerdictStanford Mg-ibogaine critique ObservatoryTMZ Hubbard / Gerber card SafetyMortality denominators BoundaryDIY / self-treatment refusal

Media

CuratedListening Library CatalogBulk media library DirectoryPeople and institutions CatalogSource catalog

Guides and standards

StartIbogaBase in 10 minutes AudienceClinician brief VisualsVisual field guide MethodMethodology EditorialStandards LogChanges feed AboutAbout IbogaBase ToolSearch